Axisa K, Vella Szijj J, Serracino Inglott A. Structure activity relationship of drugs of abuse: Synthetic cannabinoids, synthetic cathinones and fentanyl analogues. Lambert Academic Publishing. Saarbrücken; 2018.
Falzon S, Serracino-Inglott A, Grech L. Chronopharmacology in Hypertension: The case of Valsartan and Amlodipine. Germany: LAP Lambert Academic Publishing; 2018.
Heuchel D, Wirth F, Azzopardi LM. Public perception of pharmacogenetic testing: Evaluating willingness, expectations and concerns. Germany: LAP Lambert Academic Publishing; 2017.
Attard Pizzuto M, Serracino-Inglott A, Azzopardi LM. Innovative Tools to Investigate Risk in Pharmaceutical Processes. Germany: LAP LAMBERT Academic Publishing. 2016.
Busuttil A, Serracino-Inglott A, Azzopardi LM. Use of Quality Risk Management for Ensuring Good Distribution Practice. Germany: LAP LAMBERT Academic Publishing. 2014.
Camilleri A, Serracino-Inglott A, Azzopardi LM. Pressure Sores - Epidemiology and Cost of Treatment in a Geriatric Setting. Germany: LAP LAMBERT Academic Publishing. 2014.
Abdilla M, Azzopardi LM, Serracino-Inglott A. Evaluating first aid practice in schools. Germany:LAP LAMBERT Academic Publishing. 2013.
Attard A, Cilia M, Serracino-Inglott A. The bioequivalence of doxazosin slow release tablets: A pilot study. 2013
Attard K, Azzopardi LM, Zarb Adami M. Waste management in pharmacy. 2013
Cassar D, Azzopardi LM, Serracino-Inglott A. Chronopharmacology in hypertension: The case for perindopril and valsartan. 2013
Ciantar J. Shoemake C, Azzopardi LM. Drug Design At The Peroxisome Proliferator-Activated Receptor. Germany: Lap Lambert Academic Publishing, 2013.
Sammut Bartolo N, Azzopardi LM, Serracino-Inglott A. Improving the yield in the production of slow release pellets. Germany: LAP LAMBERT Academic Publishing. 2013.
Tabone F, Azzopardi LM, Serracino-Inglott A. Perception of the community pharmacist: Impact of pharmacy services and development of pharmacist prescribing. 2013
Wirth F, Azzopardi LM, Serracino-Inglott A.Quality management system for clinical pharmacy services: quality assurance for pharmacist professional services. Scholars Press. 2013
Cini J, Zarb Adami M. Pharmaceutical statistics: Malta, where does it stand? 2012
Scicluna CA, Azzopardi LM, Serracino-Inglott A. Validation instruments for community pharmacy: An update. 2012
Baldacchino MD. The use of NSAIDs and patient safety. 2011